Aniridia is a congenital disorder that causes severe eye problems, and also affects metabolism sometimes resulting in severe obesity. It is associated with mutation of a major developmental gene, called PAX6. People born with aniridia have no irises in their eyes, often are legally blind, and whatever eyesight they have continually worsens with age. The disease is uncommon, but disorders associated with genetic mutations can involve common eye problems, including cataracts and glaucoma.
To better understand and treat aniridia and other disorders involving the PAX6 gene, researchers and clinicians at the University of Virginia are combining clinical research, patient treatment and powerful basic science investigations.
They have organized for this weekend a major symposium focused on congenital eye disorders and the PAX6 gene, bringing together top researchers from the University and around the nation and Europe, along with patients living with aniridia and their families.
The organizers are Rob Grainger, W.L. Lyons Brown Professor of Biology, and Dr. Peter Netland, Vernah Scott Moyston Professor and Chair of Ophthalmology. Both are members of UVAs Brain Institute, and are research collaborators.
In his studies, Grainger uses frogs that are mutated to mimic aniridia and other eye disorders. Netland treats congenital eye disorders and conducts clinical research.
Here, the two colleagues explain for UVA Today readers their research and the goals of the 2019 John F. Anderson Symposium, Aniridia-PAX6 and Beyond
Q. Why did you organize this particular kind of symposium, connecting how eyes develop before birth and genetic diseases that can follow?
Grainger: Each of us works on different perspectives concerning eye formation. In my lab, we focus on how the eye is constructed during embryonic development; in Peter Netlands practice, on how to treat diseases that affect these processes.
These are complementary approaches two sides of the same coin. In one case we focus on the assembly of the eye, and in the other, what occurs when the eye is not constructed properly, leading to multiple serious consequences for the patient.
This interplay highlights the importance of looking at these two perspectives together, a collaboration in this case between the two of us (one in the School of Medicine and the other in the College of Arts & Sciences) each providing insights for the other.
Netland: The value of this kind of interaction has motivated us to bring together many of the worlds experts who pursue these two perspectives, including as well a third group: patients and their families who want to learn more about these diseases and treatments. There are few meetings held with this sort of three-way interaction in mind, and we anticipate that many fruitful insights and collaborations will emerge.
Q. Dr. Netland, why is aniridia an area of particular interest to you?
Netland: More than 20 years ago, I spent an extended period of time in the Middle East and India, where there are high rates of consanguinity and congenital eye disorders, which led to a book I produced about pediatric glaucomas, other scholarly contributions and development of my clinical skills. About 20 years ago, I cared for an infant with aniridia and the family of that patient. The potentially disabling issues for the patient, which involved all parts of the eye, and the compelling issues that the family were dealing with drew me toward this condition.
Another patient was very influential to me, because she was a patient advocate and mother of an affected child. I began to see increasingly larger numbers of patients with congenital eye disorders and aniridia, and I developed further clinical and academic interests in the topic.
Around 20 years ago, we started biannual meetings with the patient advocacy group Aniridia Foundation International, and developed connections with other patient support groups, which helped shape the direction of our efforts. With increasing contact with the patients and their families, I became deeply interested in trying to help these patients.
About 20 years ago, I cared for an infant with aniridia and the family of that patient. The potentially disabling issues for the patient, which involved all parts of the eye, and the compelling issues that the family were dealing with drew me toward this condition.
- Dr. Peter Netland
This is a disease that results from damage to the gene PAX6, already known to be perhaps the most fundamental gene involved in eye formation overall and consequently affecting the entire visual system. However, we knew much less about how to treat the many facets of this disorder; for example, cataract, glaucoma and corneal opacification (scarring), which are frequently acquired by patients. Some of these problems are common in the general population, and have broad significance. Many advances have been made in the past, but there is much more progress that is needed for the future.
Q. Why do you use frogs in your eye research, Professor Grainger?
Grainger: We have been examining eye development in frog embryos for over 20 years in my lab, initially because so much embryology, going back to the beginning of the 20th century, was done on these large, easy-to-obtain-and-raise embryos.
In the early days, we were learning how the different parts of the eye, notably the lens and retina, are formed by interactions between parts of the embryo to form a coordinated whole organ exactly the interactions that are disturbed when things go awry in aniridia patients.
Q. Six years ago the Grainger lab developed a gene-editing technique that allows you to mimic human lesions. How is this advancing eye research?
Grainger: While the utility of the frog system for understanding embryological processes is undisputed, during the decades that we have been doing research, the techniques allowing us to manipulate and understand gene function have blossomed, including genome projects and more recently gene editing the ability to inactivate genes of interest to learn how they function during normal development.
In 2013, we published our first paper using this new technology to inactivate genes critical for eye formation in frogs and to follow in precise detail how things go awry. This has allowed us to make important clarifications in how these genes contribute to development of the eye. Because the frog eye develops much as the human eye, these mutations help us look in detail in a way not feasible in human embryos; thereby allowing us to understand how these genetic errors lead to the problems that occur in human patients. Specifically, we have made mutations in frogs in the PAX6 gene that lead to frogs having aniridia, with features of the animals strikingly similar to those in human patients.
These are complementary approaches two sides of the same coin. In one case we focus on the assembly of the eye, and in the other, what occurs when the eye is not constructed properly, leading to multiple serious consequences for the patient.
- Robert Grainger
Q. What kind of clinical research and therapies are UVA conducting that connect with the basic research?
Netland: We have looked at many of the vision-threatening eye problems in our aniridia patients. We have also found that their mutation is linked with obesity, and have performed clinical trials to evaluate the causes of this. We have performed studies to better understand the mechanisms for some of their clinical problems, such as glaucoma.
We are excited about precision medicine trials identifying patients who can benefit from a specific gene-based therapy and we recently completed a two-year clinical trial evaluating targeted gene therapy. In parallel, similar problems are under study in the frog to complement and build on the work with human patients.
Q. What future do you see for patients with eye disease as this research moves forward?
Netland: We are working with patients with known mutations of a specific gene, so naturally we are excited about precision medicine approaches to these patients. We believe that genetic-based approaches will continue to increase understanding of these diseases and will provide the basis for rational therapy for affected patients, and more broadly for others in the general population who are suffering from the same clinical problems. We believe that new imaging techniques will produce new insights in this area.
Grainger: In the frog, our lab has developed a method for efficiently creating exact patient mutations, again amplifying the opportunities for an integrated approach to precision medicine. There are opportunities with in situ gene modification and other gene-based therapies for addressing problems and improving the quality of life of patients.
Read more from the original source:
Patients, Physicians and Researchers Gather to Probe Genetic Eye Disorders - University of Virginia
- Blurred vision is a symptom of Diabetes and other conditions - Evesham Journal - May 14th, 2024
- Undiagnosed vision disorder causes reading problems in kids - WPEC - May 14th, 2024
- Here's How to Get Affordable Eye Exams and Glasses Without Insurance - CNET - May 14th, 2024
- Blurred vision is a symptom of Diabetes and other conditions - South Wales Argus - May 14th, 2024
- Could my glasses be making my eyesight worse? - The Conversation - April 8th, 2024
- Eyeglasses Improve Income as Well as Sight, Study Shows - The New York Times - April 8th, 2024
- John Berger Lost His Eyesight to Cataracts and Learned to See - Hyperallergic - April 8th, 2024
- Eye Health Facts: What You Need to Know About the Eyes - Prevention Magazine - April 8th, 2024
- Reading glasses are good for your eyes and your income : Goats and Soda - NPR - April 8th, 2024
- 'The sight to fight:' Yorktown military members make thousands of glasses for the service - News 3 WTKR Norfolk - April 8th, 2024
- How to Watch the Solar Eclipse Without Damaging Your Eyes - Verywell Health - April 8th, 2024
- Protect Your Eyes While Watching the Solar EclipseExpert Advice from NYU Langone's Dr. Nitish Mehta - NYU Langone Health - April 8th, 2024
- 10 Daily Habits That Will Help You Protect Your Eye Health - CNET - January 25th, 2024
- Undergoing cataract surgery when it's not necessary? Some do it to improve their eyesight, but it's not without risk - The Conversation Indonesia - January 25th, 2024
- Sight Care Reviews - Is It Safe to Use? The Most Important Fact to Know Before Buy! - Kent Reporter - January 25th, 2024
- Apple has big and cartoonish plans for Vision Pro's EyeSight - AppleInsider - January 25th, 2024
- National Center for Children's Vision and Eye Health at Prevent Blindness Celebrates 15th Anniversary in 2024 - PR Web - January 25th, 2024
- Understanding Computer Vision Syndrome: Causes, Symptoms, and Practical Solutions - Medriva - January 25th, 2024
- 8 Eye Issues You Should Never Ignore - Right as Rain by UW Medicine - January 9th, 2024
- Digital eye strain is a growing issue as the muscles of the eyes work overtime, warn vision experts - Fox News - January 9th, 2024
- Know the Facts About Glaucoma - MedicineNet - January 9th, 2024
- New Year, New Vision: Top Resolutions For Optimal Eye Health - ABP Live - January 9th, 2024
- Childhood Myopia and Its Impact on Vision Loss: What Causes It? - News18 - January 9th, 2024
- What you see first in optical illusion can reveal a lot about you but youll need 20/20 vision to spot hi... - The Sun - January 9th, 2024
- The Importance of Eye Care: Preventing Vision Impairments and Maintaining Good Eye Health - Medriva - December 30th, 2023
- Six ways to look after your eyes in 2024 - The Conversation - December 30th, 2023
- 6 Essential Ways to Safeguard and Improve Your Vision in 2024 - Medriva - December 30th, 2023
- SightCare Reviews - Obvious Hoax or Safe Pills That Work? Fake Scams to Avoid | Courier-Herald - Enumclaw Courier-Herald - December 30th, 2023
- SightCare Reviews - Honest Customer Warning! Real Eyesight Support or Fake Hype? - Bothell-Kenmore Reporter - December 30th, 2023
- Global Intraocular Lens Market Surges with Innovations in Vision Correction | CAGR of 5.6% - PharmiWeb.com - December 30th, 2023
- Infection of the eye, and how to protect vision - The Hindu - December 30th, 2023
- Optical Illusion Eye Test: Can you find the dog in the street in 7 seconds? - Jagran Josh - December 30th, 2023
- You have 20/20 vision if you can find the hidden chick amongst these ducks - IndiaTimes - December 30th, 2023
- Eye Doc: Look *Here* While You Drive + 8 More Genius Tips to Improve Night Vision Behind The Wheel - Yahoo Life - December 22nd, 2023
- Designer creates inclusive clothing company after losing eyesight - Fox Business - December 22nd, 2023
- What is the state of American eyesight? - USAFacts - December 22nd, 2023
- When temporary vision loss in one eye isn't a sign of stroke - Harvard Health - December 22nd, 2023
- 10 Hacks That Can Naturally Boost Your Eye Health Today - CNET - December 22nd, 2023
- SightCare Reviews (Critical Customer Warning!) Know The Sight Care Facts Before Buy - Ukiah Daily Journal - December 22nd, 2023
- Everyone can spot the building with the hole in it but only those with 20/20 vision can find the giant C... - The US Sun - December 22nd, 2023
- Flashes, shimmers and blind spots: Here's what migraine aura looks like - The Washington Post - December 22nd, 2023
- Doctors Reveal the Snack That Cuts Your Risk of Vision-Clouding Cataracts in Half - Yahoo Life - December 22nd, 2023
- Yoga For Healthy Vision: 5 Extraordinary Yogasanas To Improve Eyesight - Netmeds.com - December 22nd, 2023
- Everyone can spot the teddy bears but you have 20/20 vision if you can see the bee in the bedroom in under... - The US Sun - December 22nd, 2023
- Reindeers blue eyes act as night vision goggles to help them find food in winter - The Guardian - December 22nd, 2023
- 6 Bad Habits That Could Be Damaging Your Eyesight - Money Talks News - December 22nd, 2023
- Reindeer vision may have evolved to spot favorite food in the snowy dark of winter - Phys.org - December 22nd, 2023
- Human eyes: How they work, and their amazing anatomy - BBC Science Focus Magazine - December 22nd, 2023
- Why reindeer eyes shine blue in the winter - The Washington Post - December 22nd, 2023
- Can Everyone Unfocus Their Eyes On Command? - IFLScience - December 22nd, 2023
- You have the eyes of a hunter if you can spot the dogs owner in the picture in 8 seconds! - Jagran Josh - December 22nd, 2023
- Everyone can see the Christmas trees but you could have 20/20 vision if you can spot the star hiding in t... - The US Sun - December 22nd, 2023
- Here's how eye exams can reveal several health conditions beyond your sight - The Record (New Westminster) - December 22nd, 2023
- At Bread for the Citys vision clinic, patients can see clearly now - The Washington Post - December 13th, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or Scam (2024) | Vashon-Maury Island Beachcomber - Vashon-Maury Island Beachcomber - December 13th, 2023
- The Benefits of Donning Prescription Sunglasses for Vision Correction and Protection - Anti Aging News - December 13th, 2023
- Vision Pro training of Apple retail store employees to start soon - BGR - December 13th, 2023
- 6 Best Vitamins and Supplements for Healthy Eyes - CNET - December 13th, 2023
- Eye Health: How to Protect Eyes From Digital Strain, Vision Loss and More? 5 Tips - India.com - December 13th, 2023
- How to watch the solar eclipse without damaging your eyesight - WATE 6 On Your Side - October 16th, 2023
- Can Optical Illusions Improve Vision? Know The Best One That Benefits Eyesight - Times Now - May 17th, 2023
- Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones - April 15th, 2023
- Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference - April 15th, 2023
- GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update - April 15th, 2023
- Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow - April 15th, 2023
- Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting - April 15th, 2023
- Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference - April 15th, 2023
- Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023 - April 15th, 2023
- Oncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological... - April 15th, 2023
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 15th, 2023
- Alvotech Provides Regulatory Update on AVT02 Biologics License Application - April 15th, 2023
- Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023 - April 15th, 2023
- Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China - April 15th, 2023
- Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting - April 15th, 2023
- QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023 - April 15th, 2023
- ITM lädt zu Symposium und Messestand auf der Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig ein - April 15th, 2023
- International Carrot Day: From healthy eyesight to weight loss - 5 wonderful benefits of carrot - Zee Business - April 7th, 2023
- How the Human Eye Works | Cornea Layers/Role | Light Rays - NKCF.org - December 11th, 2022
- Eye Emergencies: Types, Symptoms, and Prevention - Healthline - November 25th, 2022
- The criteria for certification | RNIB - November 25th, 2022